Agenerase en es it fr

Agenerase Brand names, Agenerase Analogs

Agenerase Brand Names Mixture

  • No information avaliable

Agenerase Chemical_Formula


Agenerase RX_link

Agenerase fda sheet

Agenerase FDA

Agenerase msds (material safety sheet)

Agenerase Synthesis Reference

No information avaliable

Agenerase Molecular Weight

505.628 g/mol

Agenerase Melting Point

No information avaliable

Agenerase H2O Solubility

No information avaliable

Agenerase State


Agenerase LogP


Agenerase Dosage Forms


Agenerase Indication

For the treatment of HIV-1 infection in combination with other antiretroviral agents.

Agenerase Pharmacology

Amprenavir is a protease inhibitor with activity against Human Immunodeficiency Virus Type 1 (HIV-1). Protease inhibitors block the part of HIV called protease. HIV-1 protease is an enzyme required for the proteolytic cleavage of the viral polyprotein precursors into the individual functional proteins found in infectious HIV-1. Amprenavir binds to the protease active site and inhibits the activity of the enzyme. This inhibition prevents cleavage of the viral polyproteins resulting in the formation of immature non-infectious viral particles. Protease inhibitors are almost always used in combination with at least two other anti-HIV drugs.

Agenerase Absorption

No information avaliable

Agenerase side effects and Toxicity

No information avaliable

Agenerase Patient Information

Agenerase Organisms Affected

Human immunodeficiency virus